Yifeng Pharmacy (603939) — Cash Flow-to-Debt Ratio
Yifeng Pharmacy (603939) has a Cash Flow-to-Debt Ratio of 0.04x as of September 2025, meaning its operating cash flow of CN¥641.93 Million could theoretically repay 0% of its total liabilities (CN¥14.41 Billion) in one year. See Yifeng Pharmacy free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Yifeng Pharmacy Cash Flow-to-Debt Ratio (2011–2024)
Historical debt coverage capacity for Yifeng Pharmacy across 14 annual periods. Also explore 603939 net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Yifeng Pharmacy (2011–2024)
Year-by-year debt coverage analysis for Yifeng Pharmacy. For market capitalisation and broader financial context, see Yifeng Pharmacy market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.25x | CN¥4.22 Billion | CN¥16.58 Billion | ▼ -25.3% |
| 2023 | 0.34x | CN¥4.66 Billion | CN¥13.69 Billion | ▲ +3.6% |
| 2022 | 0.33x | CN¥3.92 Billion | CN¥11.92 Billion | ▲ +40.6% |
| 2021 | 0.23x | CN¥2.15 Billion | CN¥9.19 Billion | ▲ +25.6% |
| 2020 | 0.19x | CN¥1.34 Billion | CN¥7.17 Billion | ▼ -13.6% |
| 2019 | 0.22x | CN¥963.23 Million | CN¥4.47 Billion | ▲ +56.2% |
| 2018 | 0.14x | CN¥510.71 Million | CN¥3.70 Billion | ▼ -30.2% |
| 2017 | 0.20x | CN¥317.20 Million | CN¥1.60 Billion | ▲ +76.2% |
| 2016 | 0.11x | CN¥139.94 Million | CN¥1.25 Billion | ▼ -37.1% |
| 2015 | 0.18x | CN¥181.52 Million | CN¥1.02 Billion | ▼ -44.9% |
| 2014 | 0.32x | CN¥212.35 Million | CN¥655.19 Million | ▲ +8.4% |
| 2013 | 0.30x | CN¥156.71 Million | CN¥524.21 Million | ▲ +55.4% |
| 2012 | 0.19x | CN¥80.73 Million | CN¥419.63 Million | ▼ -23.8% |
| 2011 | 0.25x | CN¥122.99 Million | CN¥487.12 Million | — |